Catenin Beta Market to Witness Robust Expansion by 2028
The global catenin beta market is anticipated to grow at a significant CAGR during the forecast period. Catenin beta is also known as beta-catenin 1. It is a protein that is encoded by the CTNNB1 gene in humans and is a dual function protein that is involved in the regulation and coordination of cell, cell adhesion and gene transcription. The major factor driving the growth of the market is the rising prevalence of genetic disorders across the globe.
According to the Genetic and Rare
Diseases Information Center (GARD), an estimated 25-30 million people are
living with a genetic disorder in the US. Furthermore, catenin beta also
supports to promote the progression of tumors by suppressing the responses from
T-cell. Its activity is controlled by a large number of binding partners
affecting its stability, cellular localization and transcriptional activity.
Moreover, it enables carcinogenesis and contributes to tumor progression of
several cancers such as colon cancer, hepatocellular carcinoma, pancreatic
cancer, lung cancer and ovarian cancer.
To Request a Sample of our Report on Catenin Beta Market: https://www.omrglobal.com/request-sample/catenin-beta-market
Hence, the rising prevalence of cancer is a major factor
leveraging the market growth. According to the National Cancer Institute (NCI),
it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US
with a mortality rate of 606,520 people in 2020. Furthermore, there were 18.1
million new cases and 9.5 million cancer-related mortalities globally in 2018
which is anticipated to rise to 29.5 million and the number of cancer-related
mortalities to 16.4 million by 2040. Some major players in the market include
GlaxoSmithKline plc, Merck KGaA, and Novartis International AG, among
others.
Market Coverage
•
The market number available for – 2021-2028
•
Base year- 2021
•
Forecast period- 2022-2028
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- GlaxoSmithKline
plc, Merck KGaA, and Novartis International AG, among others.
A
full Report of Catenin Beta Market is Available @ https://www.omrglobal.com/industry-reports/catenin-beta-market
Global Catenin Beta Market Report by Segment
By Type
• BBI-801
• Exisulind
• M-101
• Nefopam
Hydrochloride
• Others
By Application
• Dermatology
• Oncology
• Genetic
Disorder
• Others
Global Catenin Beta Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment